Page 1 | Search Results | The Hematologist | American Society of Hematology

Skip Nav Destination

1-20 of 21

Sort by

Sort Order Select

Articles

Testosterone Therapy in Men Doubles the Risk for Venous Thromboembolism

Damon Houghton, MD, Stephan Moll, MD

The Hematologist (2020) 17 (2)

https://doi.org/10.1182/hem.V17.2.10235

Published: 2020

Articles

How To Treat the Patient With Antiphospholipid Antibody Syndrome Who Needs Anticoagulation?

Stephan Moll, MD

The Hematologist (2020) 17 (1)

https://doi.org/10.1182/hem.V17.1.10174

Published: 2020

Articles

Reducing the Likelihood of Harm Associated With Use of Anticoagulant Therapy

Jori May, MD, Stephan Moll, MD

The Hematologist (2019) 16 (6)

https://doi.org/10.1182/hem.V16.6.9935

Published: 2019

Articles

Is the Future of the Benign Hematology Consult Electronic?

Jori May, MD, Stephan Moll, MD

The Hematologist (2019) 16 (5)

https://doi.org/10.1182/hem.V16.5.9802

Published: 2019

Articles

Acute DVT or PE in Cancer Patients: Apixaban Reasonable to Use?

Stephan Moll, MD, Emily Nagler, MD

The Hematologist (2019) 16 (4)

Published: 2019

Articles

An Unusual Thank-You Letter: Follow-up to "An Unusual Consult: Charlie the Lemur"

Stephan Moll, MD

The Hematologist (2019) 16 (3)

https://doi.org/10.1182/hem.V16.3.9603

Published: 2019

Articles

Apixaban Versus Rivaroxaban: Which One to Use in VTE Treatment?

Damon Houghton, MD, Stephan Moll, MD

The Hematologist (2019) 16 (3)

https://doi.org/10.1182/hem.V16.3.9576

Published: 2019

Articles

Thromboprophylaxis in Ambulatory Cancer Patients: Results of the AVERT Trial

Jori May, MD, Stephan Moll, MD

The Hematologist (2019) 16 (2)

https://doi.org/10.1182/hem.V16.2.9438

Published: 2019

Articles

An Unusual Consult

Stephan Moll, MD

The Hematologist (2019) 16 (2)

https://doi.org/10.1182/hem.V16.2.9443

Published: 2019

Articles

The Year's Best in Thrombosis: ESUS – Management of Unexplained Arterial Thromboembolism

Jori May, MD, Stephan Moll, MD

The Hematologist (2018) 16 (1)

https://doi.org/10.1182/hem.V16.1.9300

Published: 2018

Articles

Updates on Usefulness of HERDOO2 Score and on Direct Oral Anticoagulant Use in Antiphospholipid Syndrome

Stephan Moll, MD

The Hematologist (2018) 15 (6)

https://doi.org/10.1182/hem.V15.6.9048

Published: 2018

Articles

Do Plasma Levels of Direct Oral Anticoagulants Correlate With Hemorrhagic and Thrombotic Complications?

Stephan Moll, MD

The Hematologist (2018) 15 (5)

https://doi.org/10.1182/hem.V15.5.8897

Published: 2018

Articles

New Herpes Zoster Vaccine: What the Hematologist Needs to Know

Luis Malpica Castillo, MD, Stephan Moll, MD

The Hematologist (2018) 15 (4)

https://doi.org/10.1182/hem.V15.4.8758

Published: 2018

Articles

Management of Heavy Menstrual Bleeding on Anticoagulation

Yasmina L. Abajas, MD, Stephan Moll, MD

The Hematologist (2018) 15 (3)

https://doi.org/10.1182/hem.V15.3.8467

Published: 2018

Articles

Antiphospholipid Syndrome: Can the Direct Oral Anticoagulants Be Used?

Stephan Moll, MD

The Hematologist (2018) 15 (2)

https://doi.org/10.1182/hem.V15.2.8329

Published: 2018

Articles

Acute Deep Vein Thrombosis: Selecting the Right Patient for Thrombolysis

Stephan Moll, MD

The Hematologist (2018) 15 (1)

https://doi.org/10.1182/hem.V15.1.8177

Published: 2018

Articles

Use of Direct Oral Anticoagulants in Patients on Hemodialysis

Stephan Moll, MD

The Hematologist (2017) 14 (6)

https://doi.org/10.1182/hem.V14.6.7794

Published: 2017

Articles

HERDOO2 Score: How Long to Treat With Anticoagulation?

Damon Houghton, MD, Stephan Moll, MD

The Hematologist (2017) 14 (4)

https://doi.org/10.1182/hem.V14.4.7468

Published: 2017

Articles

Anticoagulation Failure in Venous Thromboembolism: Should We Test for JAK2 V617F or CALR Mutations?

Brandi N. Reeves, MD, Stephan Moll, MD

The Hematologist (2017) 14 (3)

https://doi.org/10.1182/hem.V14.3.7269

Published: 2017

Articles

Testosterone Therapy: Risk Factor for Venous Thromboembolism?

Stephan Moll, MD

The Hematologist (2017) 14 (2)

https://doi.org/10.1182/hem.V14.2.7119

Published: 2017

NARROW

Testosterone Therapy in Men Doubles the Risk for Venous Thromboembolism

How To Treat the Patient With Antiphospholipid Antibody Syndrome Who Needs Anticoagulation?

Reducing the Likelihood of Harm Associated With Use of Anticoagulant Therapy

Is the Future of the Benign Hematology Consult Electronic?

Acute DVT or PE in Cancer Patients: Apixaban Reasonable to Use?

An Unusual Thank-You Letter: Follow-up to "An Unusual Consult: Charlie the Lemur"

Apixaban Versus Rivaroxaban: Which One to Use in VTE Treatment?

Thromboprophylaxis in Ambulatory Cancer Patients: Results of the AVERT Trial

An Unusual Consult

The Year's Best in Thrombosis: ESUS – Management of Unexplained Arterial Thromboembolism

Updates on Usefulness of HERDOO2 Score and on Direct Oral Anticoagulant Use in Antiphospholipid Syndrome

Do Plasma Levels of Direct Oral Anticoagulants Correlate With Hemorrhagic and Thrombotic Complications?

New Herpes Zoster Vaccine: What the Hematologist Needs to Know

Management of Heavy Menstrual Bleeding on Anticoagulation

Antiphospholipid Syndrome: Can the Direct Oral Anticoagulants Be Used?

Acute Deep Vein Thrombosis: Selecting the Right Patient for Thrombolysis

Use of Direct Oral Anticoagulants in Patients on Hemodialysis

HERDOO2 Score: How Long to Treat With Anticoagulation?

Anticoagulation Failure in Venous Thromboembolism: Should We Test for JAK2 V617F or CALR Mutations?

Testosterone Therapy: Risk Factor for Venous Thromboembolism?

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only